Search

Your search keyword '"Whooping Cough"' showing total 761 results

Search Constraints

Start Over You searched for: Descriptor "Whooping Cough" Remove constraint Descriptor: "Whooping Cough" Publisher elsevier bv Remove constraint Publisher: elsevier bv
761 results on '"Whooping Cough"'

Search Results

1. Immunogenicity of a liquid hexavalent DTaP-IPV-HB-PRP∼T vaccine after primary and booster vaccination of term and preterm infants born to women vaccinated with Tdap during pregnancy

2. Vaccination against influenza, measles, pertussis and varicella in workers in healthcare facilities in France: A national cross-sectional study in 2019

3. The decline in immunity and circulation of pertussis among Chinese population during the COVID-19 pandemic: A cross-sectional sero-epidemiological study

4. The burden of selected vaccine-preventable diseases on the secondary care health system in England: Results from a five-year administrative healthcare dataset

5. Impact of vaccinating pregnant women against pertussis on hospitalizations of children under one year of age in a tertiary hospital in Catalonia

6. Development of a cell line-based in vitro assay for assessment of Diphtheria, Tetanus and acellular Pertussis (DTaP)-induced inflammasome activation

7. Decay of anti-Bordetella pertussis antibodies in women of childbearing age following COVID-19 non-pharmaceutical measures

8. Predicting HPV vaccination among Tdap vaccinated adolescents in Georgia at the county level☆

9. Flu and pertussis vaccination during pregnancy in Geneva during the COVID-19 pandemic: A multicentric, prospective, survey-based study

10. A phase 2 randomized controlled dose-ranging trial of recombinant pertussis booster vaccines containing genetically inactivated pertussis toxin in women of childbearing age

11. Epidemiology, prevention and control of pertussis in Spain: New vaccination strategies for lifelong protection

12. Retesting the hypothesis that early Diphtheria-Tetanus-Pertussis vaccination increases female mortality: An observational study within a randomised trial

13. Pertussis burden and acellular pertussis vaccine effectiveness in high risk children

14. Fourteen years of the Pregnancy Registry on maternal immunisation with a reduced-antigen-content tetanus-diphtheria-acellular pertussis (Tdap) vaccine

15. Vaccination programs for pregnant women in Europe, 2021

16. Protective effect of exclusive breastfeeding and effectiveness of maternal vaccination in reducing pertussis-like illness

17. Estimating Bordetella pertussis seroprevalence in adolescents and young adults in Mexico using the 2012 National Health and Nutrition Survey (ENSANUT)

18. Prevalence of B. pertussis infection in children with clinically suspected pertussis

19. Effectiveness of rapid multiplex polymerase chain reaction for early diagnosis and treatment of pertussis

20. Construction and evaluation of a pertactin-deficient live attenuated pertussis vaccine candidate BPZE1 derivative

21. Pertussis among patients with clinically compatible illness in the Amhara Regional State, Ethiopia

22. Clinical repercussions in pertussis infants post-Tdpa vaccination of pregnant woman: An immunization success?

23. Impact of maternal diphtheria-tetanus-acellular pertussis vaccination on pertussis booster immune responses in toddlers: Follow-up of a randomized trial

24. An observational study of antibody responses to a primary or subsequent pertussis booster vaccination in Australian healthcare workers

25. Current status of pertussis vaccination during pregnancy and influencing factors in Korea

26. Determination of serum neutralizing antibodies reveals important difference in quality of antibodies against pertussis toxin in children after infection

27. Impact of Tdap vaccine during pregnancy on the incidence of pertussis in children under one year in Brazil – A time series analysis

28. Safety of maternal pertussis vaccination on pregnancy and birth outcomes: A prospective cohort study

29. Evaluating the cost-effectiveness of maternal pertussis immunization in low- and middle-income countries: A review of lessons learnt

30. Vaccination coverage rates for Diphtheria, Tetanus, Poliomyelitis and Pertussis booster vaccination in France between 2013 and 2017: Learnings from an analysis of National Health System Real-World Data

31. Enhanced exploration of chronic cough using Improved Convolutional Neural Networks and remote monitoring harnessing Internet of Things (IoT)

32. ADVANCE system testing: Can safety studies be conducted using electronic healthcare data? An example using pertussis vaccination

33. ADVANCE system testing: Benefit-risk analysis of a marketed vaccine using multi-criteria decision analysis and individual-level state transition modelling

34. Adapting Center for Disease Control and Prevention's immunization quality improvement program to improve maternal vaccination uptake in obstetrics

35. Brand-specific rates of pertussis disease among Wisconsin children given 1–4 doses of pertussis Vaccine, 2010–2014

36. Pertussis and influenza immunisation coverage of pregnant women in New Zealand

37. Immunization for Pregnant Women: A Call to Action

38. Delivering prenatal pertussis vaccine through maternity services in England: What is the impact on vaccine coverage?

39. A highly sensitive one-tube nested quantitative real-time PCR assay for specific detection of Bordetella pertussis using the LNA technique

40. Psychosocial determinants of pertussis and influenza vaccine uptake in pregnant women: A prospective study

41. Factors associated with Tdap vaccination receipt during pregnancy: a cross-sectional study

42. Impact of Pertussis on the Italian population: Analysis of hospital discharge records in the period 2001–2014

43. Impact of the adolescent pertussis booster dose on the incidence of pertussis in British Columbia and Quebec, Canada

44. Pertussis vaccines: The first hundred years

45. Cost-effectiveness analysis of universal adult immunization with tetanus-diphtheria-acellular pertussis vaccine (Tdap) versus current practice in Brazil

46. Surfaceome analysis of Australian epidemic Bordetella pertussis reveals potential vaccine antigens

47. Whole blood based point-of-care assay for the detection of anti-pertussis toxin IgG antibodies

48. Evaluating the impact of a continued maternal pertussis immunisation programme in England: A modelling study and cost-effectiveness analysis

49. Comparison of whole-cell versus acellular pertussis vaccine effectiveness in school clusters of pertussis, France, 2013

50. Acceptance of pregnant women's vaccination against pertussis among French women and health professionals: PREVACOQ-1 and -2 studies

Catalog

Books, media, physical & digital resources